IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis.

Background and aims Patients with severe alcohol-associated hepatitis (AH) have high mortality. Corticosteroids improve survival only for 30 days. We targeted inflammation, cellular injury, and gut leakiness in a randomized clinical trial comparing combination therapy to corticosteroids on 180-day s... View More